Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

90 5 Major Histocompatibility Complex Modulation and Loss
14 Geuze HJ. Immunol Today 1998; 19:
282±287.
15 Denzin LK, Cresswell P. Cell 1995; 82:
155±165.
16 Kropshofer H, Arndt SO, Moldenhauer
G, Hammerling GJ,Vogt AB.
Immunity 1997; 6: 293±302.
17 Kropshofer H,Vogt AB, Thery C, Armandola
EA, Li BC, Moldenhauer G,
Amigorena S, Hammerling GJ.
EMBO J 1998; 17: 2971±2981.
18 van Ham M, van Lith M, Lillemeier B,
Tjin E, Grçneberg U, Rahman D,
Pastoors L, van Meijgaarden K, Roucard
C,Trowsdale J, Ottenhoff T,
Pappin D, Neefjes J. J Exp Med 2000;
191: 1127±1135.
19 Kirszenbaum M, Djoulah S, Hors J,
SeGall I, de Oliveira EB, Prost S,
Dausset J, Carosella ED. Hum Immunol
1997; 53: 140±147.
20 Carosella ED, Dausset J, Kirszenbaum
M. Immunol Today 1996; 17: 407±
409.
21 Riteau B, Rouas-Freiss N, Menier C,
Paul P, Dausset J, Carosella ED. JImmunol
2001; 166: 5018±5026.
22 LeBouteiller P, Blaschitz A. Immunol
Rev 1999; 167: 233±244.
23 Diehl M, Mçnz C, Keilholz W, Stevanovic
S, Holmes N, Loke YW, Rammensee
HG. Curr Biol 1996; 6: 305±
314.
24 Le Gal F-A, Riteau B, Sedlik C, Khalil-Daher
I, Menier C, Dausset J,
Guillet J-G, Carosella ED, Rouas-
Freiss N. Int Immunol 1999; 11: 1351±
1356.
25 Lopez-Botet M, Bellon T. Curr Opin
Immunol 1999; 11: 301±307.
26 Ferrone S, Marincola FM. Immunol
Today 1995; 16: 487±494.
27 GarridoF, Ruiz-CabelloF, Cabrera T,
Perez-Villar JJ, LÕpez-Nevot MA,
Duggan-Keen M, Stern PL. Immunol
Today 1997; 18: 89±95.
28 Algarra I, Cabrera T, GarridoF
Human Immunol 2000; 61: 65±73.
29 Sette A, Chesnut R, Fikes J. Immunogenet
2001; 53: 255±263.
30 Fournel S, Huc X, Aguerre-Girr M,
Solier C, Legros M, Praud-Brethenou
C, Moussa M, Chaouat G, Berrebi
A, Bensussan A, Lenfant F, Le
Bouteiller P. Tissue Antigens 2000; 55:
510±518.
31 Diederichsen AC, Hansen TP, Nielsen
O, Fenger C, Jensenius JC,
Christensen PB, Kristensen T,
Zeuthen J. Int J Cancer 1998; 79: 283±
287.
32 Tait BD. Hum Immunol 2000; 61: 158±
165.
33 Koopmann LA, Corver WE, van den
Slik AR, Gipyhart MJ, Fleuren GJ.
J Exp Med 2000; 191: 961±975.
34 Parmiani G. Keio J Med 2001; 50: 86±
90.
35 Rosenberg S,Yang JC, Douglas J,
Schwartzentruber PH, Marincola
FM, Topalian SL, Restifo NP, Dudley
ME, Schwarz SL Spiess PJ, Wunderlich
JR, Parkhurst MR, Kawakami Y,
Seipp CA, Einhorn JH,White DE.
Nat Med 1998; 4: 321±327.
36 Rosenberg SA, Zhai Y,Yang JC,
Schwartzentruber DJ, Hwu P, Marincola
FM, Topalian S, Restifo N,
Seipp CA, Einhorn JH, Roberts B,
White DE. J Natl Cancer Inst 1998; 90:
1894±1900.
37 Armstrong TD, Clements VK, Martin
BK, Ting JP, Ostrand-Rosenberg
S. Proc Natl Acad Sci USA 1997;
94: 6886±6891.
38 Schultze JL, Maecker B, von Bergwelt-Baildon
MS, Anderson KS,
Vonderheide RH. Vox Sanguinis 2001;
80: 81±89.
39 Coulie PG, Ikeda H, Baurain JF,
Chiari R. Adv Cancer Res 1999; 76:
213±242.
40 Rees RC, Mian S. Cancer Immunol Immunother
1999; 48: 374±381.
41 Ruiz-CabelloF GarridoF. Immunol
Today 1998; 19: 539±542.
42 Marincola FM, Jaffee EM, Hicklin
DJ, Ferrone S. Adv Immunol 2000; 74:
181±273.
43 Carosella ED, Rouas-Freiss N, Paul P,
Dausset J. Immunol Today1999; 20: 60±
62.
44 Algarra I, Collado A, Garrido F. Int
J Clin Lab Res 1997; 27: 95±102.
45 Goodfellow PN, Jones EA,Van Heyningen
V, Solomon E, Bobrow M,
MiggianoV, Bodmer WF. Nature
1975; 254: 267±269.